| 000 | 01541 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517225808.0 | ||
| 264 | 0 | _c20190514 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1478-6362 | ||
| 024 | 7 |
_a10.1186/s13075-018-1645-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSergeant, Jamie C | |
| 245 | 0 | 0 |
_aPrediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS). _h[electronic resource] |
| 260 |
_bArthritis research & therapy _c07 2018 |
||
| 300 |
_a147 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aHyrich, Kimme L | |
| 700 | 1 | _aAnderson, James | |
| 700 | 1 | _aKopec-Harding, Kamilla | |
| 700 | 1 | _aHope, Holly F | |
| 700 | 1 | _aSymmons, Deborah P M | |
| 700 | 1 | _aBarton, Anne | |
| 700 | 1 | _aVerstappen, Suzanne M M | |
| 773 | 0 |
_tArthritis research & therapy _gvol. 20 _gno. 1 _gp. 147 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13075-018-1645-5 _zAvailable from publisher's website |
| 999 |
_c28629998 _d28629998 |
||